Teva Respiratory and LinkedIn posts

Quote

anonymous

Guest
Dude, are you really that desperate to whore out dialogue about your "Has-Been" division and sinking ship on LinkedIn? Come on TC, you can't fish around for future Cinqair reps on that site. Everyone knows your game. Go try posting on MedReps or possibly Craigslist. No one wants to sell that dog let alone have to report to one of your nit whit managers. You guys are done, just face it. And you're only hurting yourself for future employment. You might want to disassociate yourself publicly with that brand.
 


anonymous said:
Dude, are you really that desperate to whore out dialogue about your "Has-Been" division and sinking ship on LinkedIn? Come on TC, you can't fish around for future Cinqair reps on that site. Everyone knows your game. Go try posting on MedReps or possibly Craigslist. No one wants to sell that dog let alone have to report to one of your nit whit managers. You guys are done, just face it. And you're only hurting yourself for future employment. You might want to disassociate yourself publicly with that brand.
Click to expand...
Craigslist! Hysterical. Think this shithead is finally reaping what he has sown.
 


Why are there so many openings? I heard they filled the ones they had from their re-alignments, but now see new ones on their career job site. Are they adding new territories? Getting Sub-Q indication? What's the leadership like there? Looking to get biologic experience and need some inside info please.
Thanks
 


anonymous said:
Why are there so many openings? I heard they filled the ones they had from their re-alignments, but now see new ones on their career job site. Are they adding new territories? Getting Sub-Q indication? What's the leadership like there? Looking to get biologic experience and need some inside info please.
Thanks
Click to expand...


Sanofi is set to launch Dupixent injectable for severe asthma on July 30th. That is why you are seeing all the openings again. The last of the Cinqair reps who were hanging on till the end have all just now started turning in their two weeks notice. Just look at the opening as of Monday July 16th. More to follow this week as well, especially by this Friday. They may be down to 10 reps nationally when it's all said and done.
 








You peole keep saying this is over, but they keep posting spots, filling spots and moving on. Seems to me like they continue to move forward. Former employees still seem to have a strong interest in what happens here. Quit spreading rumors and focus on your own products and company. You left here, take your attitude with you and go.
 




anonymous said:
Sanofi is set to launch Dupixent injectable for severe asthma on July 30th. That is why you are seeing all the openings again. The last of the Cinqair reps who were hanging on till the end have all just now started turning in their two weeks notice. Just look at the opening as of Monday July 16th. More to follow this week as well, especially by this Friday. They may be down to 10 reps nationally when it's all said and done.
Click to expand...
July 30th huh, where is that from? Not correct
 


Above poster is not correct. July 30th is only the start date for the Dupixent asthma reps prepping for their new indication and launch. But does it really matter? Our lonely infusion will be a distant 5th place.
Another sub-q injectable on the market puts Cinqair even further down the decision tree. Should be fun to watch Fasenra, Nucala, Dupixent and Zolair fight it out.
 


Is the pay at AZ and Sanofi that good, or is the pay here that bad? Contacted about an opening.. Just wanting a base range. Experienced B&B and Biologic reps can start in the 140s at other companies. Possible here, or laughable?
 


anonymous said:
Is the pay at AZ and Sanofi that good, or is the pay here that bad? Contacted about an opening.. Just wanting a base range. Experienced B&B and Biologic reps can start in the 140s at other companies. Possible here, or laughable?
Click to expand...

Don't waste your time unless you want to be laid off in January '19. There is a deal about to be done and Teva will be selling off entire Respiratory portfolio and the franchise will be dissolved. Teva only staying in Branded CNS/Pain market.
 

















Write your reply...
Top Bottom
Back
Quote